hemolytic anemia: autoimmune hemolytic anemia and · pdf filehemolytic anemia: autoimmune...

Download Hemolytic Anemia: Autoimmune Hemolytic Anemia and · PDF fileHemolytic Anemia: Autoimmune Hemolytic Anemia and PNH Marc Zumberg MD, FACP Associate Professor of Medicine University

If you can't read please download the document

Upload: buianh

Post on 07-Feb-2018

281 views

Category:

Documents


9 download

TRANSCRIPT

  • Hemolytic Anemia: Autoimmune Hemolytic Anemia and

    PNH

    Marc Zumberg MD, FACP Associate Professor of Medicine

    University of Florida May 2010

  • Hemolytic Anemia--Causes

    Hereditary RBC Membrane

    HS, HE, pyropoikilocytosis RBC Metabolic Defects

    EM pathway HMP shunt Nucleotide synthesis

    Hemoglobin Defects Thalassemia Abnormal variants

    Acquired Immune

    Autoimmune Isoimmune Drug

    RBC fragmentation syndromes PNH Secondary

    Renal and liver disease Misc

    Drugs, infections, chemicals, toxins, physical agents

  • Laboratory approach to the patient with suspected hemolytic

    anemia

    Laboratory CBC Reticulocyte Count Blood smear LDH Bilirubin-direct and indirect Haptoglobin Urinalysis

  • Laboratory evaluation of hemolytic anemia

    Direct Coombs

    Positive Negative

  • Coombs + Warm autoimmune hemolytic anemia

    Cold agglutinin disease

    Drug induced

    Paroxysmal Cold Hemoglobinuria

  • Coombs -

    Hemoglobinopathies Enzymopathies Membrane Defects Microangiopathic Drugs Toxins/Wilsons disease PNH Etc.

  • Autoimmune Hemolytic Anemia (AIHA)-Classification

    Warm-reacting antibodies (optimally bind red blood cells at

    37C Idiopathic Secondary

    Autoimmune disorders Immunodeficiencies Lymphoproliferative disorders Nonlymphoid malignancies Viral infections

    Mixed warm and cold antibodies

    Drug Induced

    Cold-reacting antibodies (optimally bind red blood cells

  • Audience Response Question: Coombs test

    Which of the following statements about the Coombs test and the blood bank evaluation of autoimmune hemolytic anemia is most accurate?

    A.)A positive Coombs test implies at least low grade hemolysis

    B.)Cold agglutinins are typically IgG positive on the Coombs test

    C.)The thermal amplitude of a cold agglutinin is the best predictor of clinical significance

    D.)Autoadsorption of autoantibodies are useful to define the specificity of the antibody

    E.)The eluate of concentrated IgG from patients with warm autoimmune hemolytic anemia is used to rule out alloantibodies

  • Direct Coombs test Detects antibody coating the RBC surface

    Positive test isnt necessarily diagnostic of hemolysis As many as 0.1% of healthy blood donors are positive 1-2% of hospitalized patients are positive

    Degree of hemolysis doesnt always correlate with degree of positivity

    Reardon. Am J Clin Pathol 2006:125(supl1) S71-S77

  • Direct Coombs Test

    IgG

    C3

    30-40% IgG only 10% C3 only 40-50% mixed

    37 C

  • Patterns IgG C3

    Warm AIHA

    (67%) ++ +

    (20%) + -

    (13%) - +

    Cold agglutinin disease

    - +

    Paroxsymal Cold Hemoglobinuria

    - +

    Adapted from Petz and Swisher. Immunology and Its RelaEon to Blood Transfusion. In:Clinical PracEce of Transfusion Medicine 3rd ed NY, NY. Churchill-Livingstone. 1996. P.49

  • Elution: Detection of specificity of the autoantibody

    Elute off IgG from patient RBCs Incubate with reagent RBCs to test for activity and

    specificity of the antibody

    Antibody most commonly reacts to a full RBC panel with similar agglutination strengths

    Less commonly may show a relative specificity within the Rh system such as the e antigen (WAHIA) or I (cold agglutinin)

  • Difficulty performing a Type and Screen

    + ++ +

  • Autoadsorption: Detection of Alloantibodies

    Goal is remove the autoantibody from the serum to allow the detection of alloantibodies 32% of patients with AIHA have alloantibodies 1 ml of packed autologous RBCs treated to remove the Ab

    and than incubate with patients serum at 37C

    Reardon AM J Clin Pathol 2006;125(Suppl 1):S71-77

  • Transfusion in AIHA Proceed with caution-consider risk/benefit

    ratio Transfused blood often has a short half-life Use phenotype matched blood if available

    Rh groups, Kell, Duffy, Kidd antigens If antibody shows specificity for a given antigen use

    antigen negative blood

    If cold agglutinin disease transfuse through a blood warmer

    Reardon AM J Clin Pathol 2006;125(Suppl 1):S71-77

  • Case 1 A 63 year-old previously healthy man is admitted with angina and dyspnea on exertion. He has had a lack of energy for 2 months and has also complained of some intermittent yellowing of his eyes. No prior blood counts are available. He is taking no medications and does not recall any recent illness. He denies alcohol consumption, tobacco, or illicit drug use. Laboratory data and blood smear are as follows: Hct 26% MCV 103 fL WBC count 5900/ul Retic count 7.1 % LDH 949 IU/L Coombs IgG+++, C3+

  • Warm Autoimmune Hemolytic Anemia (W-AIHA)

    IgG panagglutinating antibody directed against public epitope often on the Rh system

    Optimally bind red cells at 37C

    Primarily removed by Fc receptor macrophages in the reticuloendothelial system

    Partial phagocytosis leads to spherocytes removed by the spleen

    Less commonly or weakly fixes complement

    Packman CH. Blood Rev. 2008 Jan;22(1):17-31. PMID: 17904259

  • spherocyte

    nucleated RBC

    Positive Coombs Test

  • Diagnosis: Warm Autoimmune hemolytic Anemia

    Investigation Rule out lymphoproliferative disorder

    Consider bone marrow aspirate and biopsy

    Rule out autoimmune disorder ANA, etc

    Rule out immunodeficiency Quantitative immunoglobulins

    Rule out drugs

  • Warm autoimmune hemolytic anemia-Treatment

    Treat underlying disease if identified

    Steroids first line (1mg/kg) for one to three weeks Interfere with ability of macrophages to clear IgG coated

    RBCs Decreases antibody production 60-85% initial response (20% CR), but frequent relapses Initial quick taper, than slowly when down to 20mg (for

    2-3 months) Pulses of high dose glucocorticoids may be useful in some

    who fail King. Semin Hematol. 2005; 42:131-136

    Kessler. Clin Advances in Hemaotol Onc. 2008; 6(10):739-41

  • Warm autoimmune hemolytic anemia-Treatment

    Splenectomy

    Consider in two-three weeks if no response to steroids 2/3 respond, but relapses occur Ensure immunizations and education about infectious risk

    Pneumoccus, meningococcus, and hemophilis influenza type B ??? Prophylactic antibiotics

    Higher incidence of post-splenectomy venous thrombembolism and pulmonary hypertension

    High incidence of antiphospholipid antibodies

    Kessler. Clin Advances in Hemaotol Onc. 2008; 6(10):739-41 Crary. Blood. 2009 Oct 1;114(14):2861-8.

  • Rituximab Chimeric monoclonal antibody targeting

    CD-20 on mature B Cells

    Bussone . AM J Hematol. 2009: 84:153-157

    Median time to response 6 weeks (2-16)

  • Treatment-Other 10% refractory to both steroids and splenectomy Other immunosuppressants

    Immuran Cyclophosphamide Cyclosporine Danazol IVIG

    Not as effective as in ITP

    Paucity of randomized trials to suggest which agent is superior

    Responses may be delayed several months Kessler. Clin Advances in Hemaotol Onc. 2008; 6(10):739-41

  • Case 2 A 63 year-old previously healthy male complains of fatigue and lack of energy for 2 months. He denies a history of fever, chills, night sweats or weight loss, but reports painful blue digits in the cold. A routine CBC drawn 1 year ago was normal. He is taking no new medications and does not recall any recent illness. He denies alcohol consumption, tobacco, or illicit drug use Laboratory data and blood smear are as follows: Hct 26% MCV 133 fL WBC count 5900/ul Retic count 7.1 % LDH 949 IU/L Coombs IgG-, C3++

  • Cold agglutinin Disease

    IgM antibody optimally binds to RBCs at lower temperatures Fixes complement

    Direct lysis of red blood cells Removal of C3b-coated RBCs by the liver

    Titers

  • Blood Bank evaluation-Thermal Amplitude Test

    Keep blood at 37C from point of bedside collection to testing initial screening is often at 20C or room

    temperature

    Reardon. Am J Clin Pathol 2006:125(supl1) S71-S77

  • Cold Agglutinin Disease: Diagnostic Criteria

    1.) Clinical evidence of an acquired hemolytic anemia

    2.) Positive Coombs test using anti-C3

    3.) Negative Coombs test using anti-IgG

    4.) Presence of cold agglutinin with reactivity up to 30C

    5.) Cold agglutinin titer at 4C > 256

    Petz. Blood Reviews. 2008; 22: 1-15

  • Spurious marked elevation of MCV, MCHC may occur Agglutination will abate with warming

    RBC agglutination

    Cooling of blood during passage through acral parts of the body allows cold agglutinins to bind to the RBC leading to agglutination,

    complement binding, and hemolysis

    Berntsten. Hematology. 2007; 12(5): 361-70

  • Investigation of Cold Agglutinin Disease

    Consider infectious etiologies such as Mycoplasma or Epstein-Barr virus

    Consider lymphoma or other lymphoproliferative disorders Serum protein electrophoresis (SPEP) Bone marrow biopsy if no obvious infection Consider radiologic imaging

    Berntsten. Hematology. 2007; 12(5): 361-70

  • Cold Agglutinin Disease Monoclonal band can be detected in the majority of

    patients on serum protein electrophoresis/im